TY  - GEN
AU  - Vergnenègre,A
AU  - Perol,M
AU  - Pham,E
TI  - Cost analysis of hospital treatment--two chemotherapic regimens for non-surgical non-small cell lung cancer. GFPC (Groupe Français Pneumo Cancérologie)
SN  - 0169-5002
PY  - 1996///0904
KW  - Adult
KW  - Aged
KW  - Antibiotics, Antineoplastic
KW  - economics
KW  - Antineoplastic Agents, Phytogenic
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - Cost-Benefit Analysis
KW  - Direct Service Costs
KW  - statistics & numerical data
KW  - Drug Costs
KW  - Female
KW  - France
KW  - Health Services Research
KW  - methods
KW  - Hospital Costs
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mitomycins
KW  - Models, Economic
KW  - Oncology Service, Hospital
KW  - Prospective Studies
KW  - Quality-Adjusted Life Years
KW  - Retrospective Studies
KW  - Sensitivity and Specificity
KW  - Treatment Outcome
KW  - Vinblastine
KW  - analogs & derivatives
KW  - Vindesine
KW  - Vinorelbine
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/0169-5002(95)00511-0
ER  -